We've received your request
You will be notified by email when the transcript and captions are available. The process may take up to 5 business days. Please contact email@example.com if you have any questions about this request.
Researchers at Weill Cornell Medical College have discovered that a known biomarker of bone mineral density can also be used to monitor the effects of testosterone therapy in men who suffer from osteoporosis or its precursor, osteopenia.